Oramed Pharmaceuticals
ORMP
#8992
Rank
A$0.19 B
Marketcap
A$4.84
Share price
-1.46%
Change (1 day)
36.71%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): A$86.96 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are A$2 Million. In 2024 the company made an earning of -A$21.64 Million a decrease over its 2023 earnings that were of A$10.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$86.96 M-501.92%
2024 -A$21.64 Million-311.47%
2023 A$10.23 M-119.45%
2022 -A$52.6 Million39.17%
2021 -A$37.8 Million73.93%
2020 -A$21.73 Million18.53%
2019 -A$18.34 Million-16.62%
2018 -A$21.99 Million38.32%
2017 -A$15.9 Million12.51%
2016 -A$14.13 Million25.01%
2015 -A$11.31 Million18.18%
2014 -A$9.57 Million39.72%
2013 -A$6.85 Million46.4%
2012 -A$4.68 Million128.32%
2011 -A$2.05 Million-51.47%
2010 -A$4.22 Million35.21%
2009 -A$3.13 Million
2007 -A$4.91 Million607.04%
2006 -A$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
A$29.93 B 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$13.06 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.75 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$98.48 Million-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-A$39.58 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel